Document Detail


Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
MedLine Citation:
PMID:  19169210     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
T cells are critical effectors of the adaptive immune response and play an important role in cutaneous immunity. In the skin, various cell types cooperate together, from components of both the innate immunity and adaptive immunity, provide sentinel function to mediate the immune response. However, when T cell function becomes abnormal, there is a loss of normal effector immune function, and the abnormal T cells become a cause of disease as well. Mycosis fungoides (MF) is a cutaneous T cell lymphoma (CTCL) that preferentially travels to the epidermis. When skin homing T cells become malignant, the clinical consequences reflect not only the presence of the malignant cells, but likely from a complex reaction of the immune response to the malignant cell. The clinical presentation is the evolving manifestation of the steps in cancer immunosurveillance. Analysis of gene expression in MF/CTCL patients has provided support for the role of the immune response in the early phase of the disease and a loss of immune response in advance stages of MF/CTCL. This review will focus on cytokine gene expression abnormalities in the clinical stages of the disease and discuss the relationship between the clinical and immunologic abnormalities to gain a better understanding of mechanisms important in the evolution of this disease. A better understanding of the immunopathogenesis of MF/CTCL would support innovative strategies for the development of novel therapies to treat this T cell malignancy.
Authors:
H K Wong
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Giornale italiano di dermatologia e venereologia : organo ufficiale, Società italiana di dermatologia e sifilografia     Volume:  143     ISSN:  0392-0488     ISO Abbreviation:  G Ital Dermatol Venereol     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2009-01-26     Completed Date:  2009-04-03     Revised Date:  2012-07-30    
Medline Journal Info:
Nlm Unique ID:  8102852     Medline TA:  G Ital Dermatol Venereol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  375-83     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA. hwong1@hfhs.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cytokines / genetics,  immunology*
Diagnosis, Differential
Gene Expression Regulation, Neoplastic*
Humans
Lymphoma, T-Cell, Cutaneous / immunology
Mycosis Fungoides / diagnosis,  genetics,  immunology*
Psoriasis / diagnosis
Sezary Syndrome / diagnosis,  genetics,  immunology*
Skin / immunology,  pathology
Skin Neoplasms / diagnosis,  genetics,  immunology*
T-Lymphocytes / immunology*
Tumor Markers, Biological / immunology
Grant Support
ID/Acronym/Agency:
0//PHS HHS
Chemical
Reg. No./Substance:
0/Cytokines; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular biology and targeted therapy of cutaneous T-cell lymphomas.
Next Document:  The molecular pathogenesis of mycosis fungoides and Sézary syndrome.